Merck
Merck teams up with Sun on emerging markets generics
April 12, 2011Sales and Marketing India, Merck, Sun Pharma, emerging markets
Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …
Merck acquires eyecare specialist Inspire
April 6, 2011Research and Development, Sales and Marketing Inspire, Merck, eye care
Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
Merck drops oral anticoagulant
March 25, 2011Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar
Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …
Bayer-helmed oncology biomarker project launched
March 14, 2011Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology
A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
Fujifilm buys into bio with Merck acquisitions
March 2, 2011Manufacturing and Production Biomanufacturing, Fujifilm, Merck, Merck & Co, Merck/MSD Biomanufacturing Network, contract manufacturing
Japanese photography and imaging company Fujifilm continued its diversification into other sectors with the acquisition of the Merck/MSD Biomanufacturing Network, …
Merck repels jaw injury claim
February 15, 2011Sales and Marketing Fosamax, Merck, US, lawsuit
A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …
US Senate takes aim at prescription drug shortages
February 15, 2011Manufacturing and Production Merck, Zostavax, shortages, supply chain
A bill aimed at tackling the ongoing problem of prescription drug shortages in the US has been introduced in the …
Digital Pharma: Pfizer, J&J and Merck withdraw iPhone apps
January 7, 2011Medical Communications Android, Blackberry, Digital Pharma blog, Johnson & Johnson, Merck, Pfizer, apps, ipad, iphone
Big pharma companies have pulled a number of apps from the iTunes store, but it’s not a sign the industry …
Merck acquires innovative insulin firm SmartCells
December 3, 2010Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin
Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …
New chief executive for Merck & Co
December 1, 2010Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough
Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
Vytorin cuts heart problems in kidney patients
November 23, 2010Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Caelyx rights to revert back to Janssen
September 30, 2010Sales and Marketing Caelyx, Janssen, Merck
Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …
J&J and Merck heading for showdown over drug rights
September 8, 2010Sales and Marketing Johnson & Johnson, Merck, Remicade
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
Merck names manufacturing and R&D sites slated for closure
July 12, 2010Manufacturing and Production, Research and Development Merck, job cuts, manufacturing, research and development
Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …
Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
